How bad is HAART for the HEART?
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (17) , 2529-2531
- https://doi.org/10.1097/00002030-200311210-00017
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 2003
- HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophagesJournal of Clinical Investigation, 2003
- Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitorsAtherosclerosis, 2002
- Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistancePublished by Elsevier ,2002
- Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled studyAIDS, 2002
- Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileAIDS, 2001
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000
- Effect of ritonavir on lipids and post-heparin lipase activities in normal subjectsAIDS, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998